Strengthening tuberculosis (TB) prevention, diagnosis, and treatment in Southeast Asia to end TB

The U.S. Department of Health and Human Services, through its sub-agency the Centers for Disease Control and Prevention (CDC), is forecasting a cooperative agreement funding opportunity titled "Strengthening tuberculosis (TB) prevention, diagnosis, treatment, and surveillance in Asia." This initiative aims to combat tuberculosis-related morbidity and mortality in India, the Philippines, and Vietnam, which are among the top contributors to TB cases affecting the United States. The effort aligns with the America First Global Health Strategy and is part of the broader CDC mandate to develop and implement evidence-based approaches to global TB elimination. This funding opportunity is structured as a cooperative agreement, emphasizing significant involvement from CDC staff in program implementation and evaluation. The CDC intends to allocate approximately $3,000,000 in fiscal year 2026, pending availability of funds. The focus of this grant is comprehensive, spanning TB case identification, preventive treatment, curative interventions, and the enhancement of surveillance systems to ensure data-driven program decisions. Priority will be given to innovative approaches and evidence-based strategies, particularly in addressing early, asymptomatic, and drug-resistant TB cases. Grantees are expected to improve diagnostic systems through expanded testing and screening mechanisms and to deploy new, shorter, and more tolerable treatment regimens. Additionally, awardees must commit to strengthening TB surveillance to facilitate informed public health decisions and programmatic responses. These actions will build upon the CDC’s long-standing international public health expertise and reinforce partnerships in the target regions. The opportunity will support up to three awardees, and the application window is forecasted to open on April 10, 2026, with a submission deadline of June 12, 2026, by 11:59 PM Eastern Time. The award and project start dates are both estimated for September 30, 2026. Cost sharing is not required. The notice does not indicate any pre-application requirements such as letters of intent or concept notes, and submission is anticipated via Grants.gov or similar electronic means. A wide array of organizations are eligible to apply, including public and private institutions of higher education, state and local governments, Native American tribal organizations (both federally recognized and not), public housing authorities, special district governments, small and large businesses, and nonprofit organizations. This breadth of eligibility underscores CDC’s interest in engaging diverse institutions capable of driving impact in high-TB-burden settings. For questions, the CDC has listed an official contact email: [email protected]. No PDF documents or official NOFOs were linked directly in the source. Interested applicants are encouraged to monitor the Grants.gov listing for updates as the posting transitions from forecast to active status in the lead-up to April 2026.